Literature DB >> 4931496

The dyskenesias: a new therapeutic approach.

L Bucci.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4931496

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN: 0012-3714


× No keyword cloud information.
  6 in total

1.  Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.

Authors:  B K Koe
Journal:  Experientia       Date:  1975-06-15

Review 2.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

3.  What's new in the psychopharmacology of schizophrenia.

Authors:  A Rifkin; F Quitkin
Journal:  Bull N Y Acad Med       Date:  1978-10

4.  The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.

Authors:  L Bucci
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 5.  Anticholinergic medication for antipsychotic-induced tardive dyskinesia.

Authors:  Hanna Bergman; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-01-17

Review 6.  Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.

Authors:  Karla Soares-Weiser; John Rathbone; Yusuke Ogawa; Kiyomi Shinohara; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.